StocksMedium•29 May 2026•
1 min read

23andMe Agrees to $50 Million Settlement Over 2023 Data Breach Affecting 7 Million Users

Key Facts

123andMe agreed to pay a $50 million settlement in a class-action lawsuit regarding data protection.
2The lawsuit alleges the company failed to protect personal information for nearly 7 million users during a 2023 breach.

Amid intensifying regulatory scrutiny over how health-tech firms safeguard sensitive genetic information, 23andMe has moved to resolve its mounting legal liabilities. The company agreed to pay a $50 million settlement in a class-action lawsuit regarding data protection failures. The lawsuit alleges that the firm failed to protect the personal information of nearly 7 million users during a significant data breach in 2023.

This settlement arrives as the company grapples with severe operational headwinds and a struggling stock price. Compared to industry peers, 23andMe faces unique reputational risks due to the nature of its data; previous reports from Reuters highlighted that the firm has struggled with profitability and declining demand for its core DNA kits. Per market data, this $50 million payout represents a substantial hit to the company's remaining cash reserves.

Investors should watch the stock's performance at the close of May 29, 2026, to gauge market reaction to this legal resolution. Key upcoming catalysts include the US CB Consumer Confidence report on May 26, 2026, which may provide broader context on consumer sentiment toward tech services following high-profile security lapses.